Focus & Cognitive Health Research
The neurotrophic and neuroendocrine signaling pathways behind our focus and cognitive health research line.
How This Works
This research area spans several distinct mechanisms: melanocortin receptor signaling in neuroendocrine and sexual-function pathways (Kisspeptin, PT-141), proposed neurotrophic/GABAergic modulation in cognition and stress research (Selank, Semax), and sleep-related neural signaling with a genuinely unresolved mechanism (DSIP). The evidence base varies widely by compound — from PT-141's unusually deep FDA-approved clinical trial record to DSIP's decades-long, still-unsettled search for a defined receptor.
Compounds Behind This Category
DSIP (Delta Sleep-Inducing Peptide)
DSIP is a nonapeptide originally isolated from rabbit brain and studied for its association with delta (slow-wave) sleep EEG activity across several species. Despite decades of research, no dedicated DSIP receptor or definitive downstream signaling cascade has been characterized, and its relationship to endogenous sleep regulation remains genuinely unresolved in the primary literature — this uncertainty is itself a notable and honestly-reported finding, not a gap in this summary.
ExploreKisspeptin
Kisspeptin binds the KISS1 receptor (KISS1R/GPR54) on hypothalamic GnRH neurons, triggering phospholipase C activation, closure of potassium channels, and sustained depolarization — positioning it as the principal upstream regulator of pulsatile and surge GnRH release, and consequently of downstream LH/FSH secretion. A nonneuronal KISS1R pathway in astrocytes has also been identified that modulates the reproductive axis indirectly.
ExploreSelank
Selank is a synthetic, metabolically stabilized extension of the natural immunomodulatory tetrapeptide tuftsin, studied primarily in rodent models of anxiety, stress, and cognition. Proposed mechanisms include upregulation of hippocampal and prefrontal cortical BDNF, modulation of GABAergic signaling, and inhibition of enzymes that degrade endogenous enkephalins. Human data is limited to a single small resting-state fMRI study.
ExploreSemax
Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence with an added Pro-Gly-Pro tail, studied predominantly in rodent models of cerebral ischemia and in human neuroimaging studies of brain connectivity. Proposed mechanisms include modulation of neurotrophic signaling, altered hippocampal calcium dynamics, and immune/vascular gene-expression changes in ischemic brain tissue — distinct from ACTH's classical corticotropic hormone activity, which the sequence used here lacks.
Explore